Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Forensic Toxicol ; 41(1): 142-150, 2023 01.
Artículo en Inglés | MEDLINE | ID: mdl-36652069

RESUMEN

PURPOSE: MDA-19 or BZO-HEXOXIZID (N'-[(3Z)-1-(1-hexyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]-benzohydrazide), in a more recent nomenclature, was first synthesized in 2008 as a selective type-2 cannabinoid receptor (CB2) agonist due to its potential to treat neuropathic pain. In Brazil, this substance was identified in a series of 53 apprehensions between September 2021 and February 2022. Nevertheless, what intrigues toxicologists is that BZO-HEXOXIZID does not exert significant type-1 cannabinoid receptor (CB1) agonism-which is responsible for the well-known psychoactivity of Δ-9-tetrahydrocannabinol. Thus, the objective of this work is to report the first apprehension and identification of BZO-HEXOXIZID in Brazil and to discuss pharmacologically the possible reasons why a CB2 agonist has been incorporated to the illicit market. METHODS: Suspected seized samples were sent to the Laboratory of the Scientific Police of the State of Sao Paulo. After the screening, samples were confirmed for the presence of BZO-HEXOXIZID using chromatography gas-mass spectrometry, Fourier-transform infrared spectroscopy and nuclear magnetic resonance techniques. RESULTS: Of the 53 samples analyzed, 25 contained only BZO-HEXOXIZID and 28 with mixtures, of which 11 with the CB1 agonist ADB-BUTINACA. Other substances were found in association such as cocaine and caffeine. CONCLUSIONS: BZO-HEXOXIZID was detected in a series of seized materials for the first time in Brazil. Nevertheless, there are still unanswered questions regarding the use of this selective CB2 agonist as a drug of abuse.


Asunto(s)
Agonistas de Receptores de Cannabinoides , Neuralgia , Humanos , Agonistas de Receptores de Cannabinoides/farmacología , Cromatografía de Gases y Espectrometría de Masas , Brasil , Receptores de Cannabinoides
2.
Food Res Int ; 99(Pt 1): 336-347, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28784491

RESUMEN

Mate (Ilex paraguariensis A.St.-Hil.) is generally recognized as safe (GRAS status) and has a high content of alkaloids, saponins, and phenolic acids. Addition of mate extract to broilers feed has been shown to increase the oxidative stability of chicken meat, however, its effect on beef quality from animals supplemented with mate extract has not been investigated so far. Addition of extract of mate to a standard maize/soy feed at a level of 0.5, 1.0 or 1.5% w/w to the diet of feedlot for cattle resulted in increased levels of inosine monophosphate, creatine and carnosine in the fresh meat. The content of total conjugated linoleic acid increased in the meat as mate extract concentration was increased in the feed. The tendency to radical formation in meat slurries as quantified by EPR spin-trapping decreased as increasing mate extract addition to feed, especially after storage of the meat, indicating higher oxidative stability. Mate supplementation in the diet did not affect animal performance and carcass characteristics, but meat from these animals was more tender and consequently more accepted by consumers. Mate extract is shown to be a promising additive to feedlot diets for cattle to improve the oxidative stability, nutritive value and sensory quality of beef.


Asunto(s)
Alimentación Animal , Comportamiento del Consumidor , Suplementos Dietéticos , Manipulación de Alimentos/métodos , Calidad de los Alimentos , Ilex paraguariensis , Extractos Vegetales/administración & dosificación , Carne Roja/análisis , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Bovinos , Humanos , Juicio , Metabolómica/métodos , Estado Nutricional , Valor Nutritivo , Odorantes , Percepción Olfatoria , Oxidación-Reducción , Extractos Vegetales/metabolismo , Carne Roja/normas , Gusto , Percepción del Gusto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...